Drug:
Reaction: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION
20250101 - 20251231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 25138797 |
US |
2 | |
Inappropriate schedule of product administration, No adverse event, |
||||
TOCILIZUMAB, TOCILIZUMAB, |
||||
| 2 | 25138877 |
US |
55 | 2 |
Nausea, Fatigue, Weight decreased, Chills, Intestinal stenosis, Asthenia, Decreased appetite, Drug ineffective, Inappropriate schedule of product administration, Intestinal obstruction, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 3 | 25138936 |
US |
1 | |
Urticaria, Inappropriate schedule of product administration, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 4 | 25139040 |
US |
75 | 2 |
Product dispensing error, Stress, Inappropriate schedule of product administration, Thyroid hormones increased, Hypertension, |
||||
LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, ERGOCALCIFEROL, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, VITAMIN C, CALCIUM, DUPILUMAB, |
||||
| 5 | 25139064 |
US |
54 | 2 |
Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 6 | 25139109 |
US |
61 | 1 |
Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 7 | 25139110 |
US |
54 | 2 |
Wheelchair user, Inappropriate schedule of product administration, |
||||
INSULIN GLARGINE, |
||||
| 8 | 25139125 |
US |
56 | 2 |
Blood sodium decreased, Cardiac failure, Inappropriate schedule of product administration, |
||||
PERFLUOROHEXYLOCTANE, LIFITEGRAST, ACETAMINOPHEN, FISH OIL, FAMOTIDINE, DIPHENHYDRAMINE HYDROCHLORIDE, ALBUTEROL SULFATE, SPIRONOLACTONE, TIOTROPIUM BROMIDE INHALATION SPRAY, ROSUVASTATIN, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, MONTELUKAST, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, DAPAGLIFLOZIN, IPRATROPIUM BROMIDE, GABAPENTIN, FUROSEMIDE, ESTRADIOL, ERYTHROMYCIN LACTOBIONATE, DULOXETINE HYDROCHLORIDE, DULOXETINE, CLONAZEPAM, CELECOXIB, BUDESONIDE, BACLOFEN, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, AMANTADINE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, |
||||
| 9 | 25139246 |
US |
78 | 1 |
Inappropriate schedule of product administration, Device defective, Product label issue, |
||||
USTEKINUMAB, USTEKINUMAB, |
||||
| 10 | 25139532 |
CA |
2 | |
Ankylosing spondylitis, Inappropriate schedule of product administration, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, METOPROLOL TARTRATE, METOPROLOL, HYDROCHLOROTHIAZIDE, |
||||
| 11 | 25139596 |
GB |
||
Device issue, Device defective, Inappropriate schedule of product administration, |
||||
GOLIMUMAB, GOLIMUMAB, |
||||
| 12 | 25139608 |
US |
72 | 1 |
Inappropriate schedule of product administration, Poor quality product administered, Product container issue, Suspected counterfeit product, |
||||
| 13 | 25139832 |
US |
63 | 1 |
Dysphagia, Asthenia, Hypersensitivity, Muscle spasms, Drug interaction, Inappropriate schedule of product administration, |
||||
RIPRETINIB, |
||||
| 14 | 25139890 |
US |
67 | 1 |
Inappropriate schedule of product administration, Psoriasis, |
||||
IXEKIZUMAB, IXEKIZUMAB, |
||||
| 15 | 25140074 |
US |
70 | 2 |
Chemotherapy, Illness, Feeding disorder, Inappropriate schedule of product administration, |
||||
PANCRELIPASE, |
||||
| 16 | 25140144 |
US |
2 | |
Inappropriate schedule of product administration, |
||||
MINOXIDIL, |
||||
| 17 | 25140285 |
US |
||
Fatigue, Inappropriate schedule of product administration, |
||||
OSIMERTINIB, OSIMERTINIB, CABOZANTINIB, |
||||
| 18 | 25140308 |
CA |
33 | 1 |
Blood pressure systolic increased, Drug hypersensitivity, Lower respiratory tract infection bacterial, Lower respiratory tract infection viral, Urticaria, Inappropriate schedule of product administration, |
||||
DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, KETOTIFEN FUMARATE, MONTELUKAST, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, RANITIDINE, |
||||
| 19 | 25140329 |
US |
||
Drug dependence, Rebound nasal congestion, Incorrect product administration duration, Inappropriate schedule of product administration, |
||||
| 20 | 25140602 |
US |
26 | 1 |
Therapy cessation, Inappropriate schedule of product administration, |
||||
PEMBROLIZUMAB, |
||||
| 21 | 25141119 |
PH |
||
Pulmonary congestion, Cardiac failure congestive, Pneumonia, Dialysis, Cough, Asthenia, Wrong technique in product usage process, Inappropriate schedule of product administration, Underdose, |
||||
TOLVAPTAN, |
||||
| 22 | 25141199 |
US |
2 | |
Poor quality product administered, Inappropriate schedule of product administration, Product taste abnormal, |
||||
IBUPROFEN, |
||||
| 23 | 25141302 |
US |
43 | 1 |
Crohn^s disease, Inappropriate schedule of product administration, Influenza like illness, Nasopharyngitis, Product dose omission issue, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 24 | 25141349 |
US |
85 | 1 |
Extra dose administered, Inappropriate schedule of product administration, |
||||
DULAGLUTIDE, |
||||
| 25 | 25141414 |
US |
2 | |
Blood glucose decreased, Discomfort, Device issue, Inappropriate schedule of product administration, |
||||
INSULIN LISPRO, |
||||
| 26 | 25141439 |
US |
2 | |
Abdominal discomfort, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 27 | 25141544 |
BR |
10 | 2 |
Inappropriate schedule of product administration, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 28 | 25141606 |
US |
26 | 2 |
Rebound eczema, Dry skin, Pruritus, Intentional dose omission, Inappropriate schedule of product administration, |
||||
DUPILUMAB, BETAMETHASONE DIPROPIONATE, |
||||
| 29 | 25141615 |
US |
73 | 1 |
Inappropriate schedule of product administration, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, |
||||
| 30 | 25141623 |
US |
21 | 1 |
Skin irritation, Pruritus, Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 31 | 25141638 |
US |
47 | 2 |
Inappropriate schedule of product administration, |
||||
INSULIN GLARGINE, |
||||
| 32 | 25141648 |
US |
1 | |
Eye pain, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 33 | 25141659 |
US |
65 | 2 |
Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 34 | 25141676 |
US |
19 | 1 |
Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 35 | 25141910 |
GB |
2 | |
Colitis ulcerative, Sinus pain, Inappropriate schedule of product administration, Headache, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 36 | 25142124 |
US |
40 | 2 |
Implant site haematoma, Nasopharyngitis, Oropharyngeal pain, Injection site pain, Hyperhidrosis, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 37 | 25142138 |
US |
1 | |
Product dose omission issue, Inappropriate schedule of product administration, |
||||
MEPOLIZUMAB, |
||||
| 38 | 25142158 |
CA |
53 | 1 |
Bronchiectasis, Deep vein thrombosis, Haematochezia, Pulmonary embolism, Rectal haemorrhage, Tubulointerstitial nephritis, Cerebrovascular accident, Adverse drug reaction, Burns second degree, Cardiac murmur, Catarrh, Confusional state, Depression, Steroid dependence, Parosmia, Dysgeusia, Arthritis, Swollen tongue, Gingival pain, Stress, Hypopnoea, Tinnitus, Weight decreased, Impaired quality of life, Impaired work ability, Loss of personal independence in daily activities, Migraine, Nightmare, Somnolence, Vertigo, Eczema, Palpitations, Abdominal discomfort, Pain, Systemic lupus erythematosus, Pyrexia, Colitis ulcerative, Pain in extremity, Frequent bowel movements, Rash, Rhinitis, COVID-19, Fatigue, Headache, Condition aggravated, Drug ineffective, Medication error, Off label use, Inappropriate schedule of product administration, Intentional product use issue, Product use in unapproved indication, Accidental overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ALBENDAZOLE, ALBENDAZOLE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, DAPAGLIFLOZIN, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, FUROSEMIDE, GABAPENTIN, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OXYCODONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ROSUVASTATIN, ROSUVASTATIN, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, ERGOCALCIFEROL, WARFARIN SODIUM, WARFARIN, WARFARIN SODIUM, WARFARIN, WARFARIN SODIUM, WARFARIN, WARFARIN SODIUM, WARFARIN, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, CANDESARTAN, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, WARFARIN SODIUM, WARFARIN, WARFARIN SODIUM, WARFARIN, WARFARIN, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, MESALAMINE, VEDOLIZUMAB, VEDOLIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, EPINEPHRINE, ADRENALINUM, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, LISDEXAMFETAMINE DIMESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CANDESARTAN CILEXETIL, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, LEVOTHYROXINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, OXYCODONE HYDROCHLORIDE, OXYCODONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, AMLODIPINE BESYLATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, DORZOLAMIDE HYDROCHLORIDE, DORZOLAMIDE, FESOTERODINE FUMARATE, FOLIC ACID, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, LATANOPROST, LATANOPROST, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, RAMIPRIL, RIVAROXABAN, TAMSULOSIN HYDROCHLORIDE, TOFACITINIB, TOFACITINIB, MINERAL OIL, NITROFURANTOIN, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), TETRAHYDROZOLINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, LANSOPRAZOLE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, EMPAGLIFLOZIN, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, DORZOLAMIDE, PREGABALIN, MINERAL OIL, NAPHAZOLINE HYDROCHLORIDE, AMLODIPINE, AMLODIPINE, TETRAHYDROZOLINE HYDROCHLORIDE, |
||||
| 39 | 25142500 |
US |
12 | 2 |
Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 40 | 25142709 |
CN |
75 | 1 |
Delirium, Dysphoria, Inappropriate schedule of product administration, Incorrect dose administered, |
||||
CASPOFUNGIN ACETATE, DEXTROSE MONOHYDRATE, DEXTROSE, VORICONAZOLE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 41 | 25138169 |
US |
2 | |
Joint swelling, Condition aggravated, Arthralgia, Inappropriate schedule of product administration, |
||||
SARILUMAB, |
||||
| 42 | 25138186 |
US |
9 | 2 |
Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 43 | 25138197 |
US |
22 | 1 |
Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 44 | 25138231 |
US |
24 | 2 |
Blindness, Fall, Fatigue, Back pain, Pain in extremity, Inappropriate schedule of product administration, |
||||
OFATUMUMAB, OFATUMUMAB, PREDNISONE, |
||||
| 45 | 25138242 |
US |
55 | 2 |
Foreign body sensation in eyes, Condition aggravated, Eye swelling, Condition aggravated, Ocular hyperaemia, Condition aggravated, Dry eye, Vision blurred, Condition aggravated, Eye irritation, Condition aggravated, Eye pruritus, Condition aggravated, Eczema, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 46 | 25138267 |
US |
||
Osteopenia, Inappropriate schedule of product administration, |
||||
BENRALIZUMAB, |
||||
| 47 | 25138322 |
US |
1 | |
Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 48 | 25138399 |
US |
2 | |
Taste disorder, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 49 | 25138489 |
US |
70 | |
Extra dose administered, Inappropriate schedule of product administration, |
||||
DULAGLUTIDE, |
||||
| 50 | 25138503 |
US |
61 | 1 |
Lower respiratory tract infection, Nasal polyps, Condition aggravated, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 51 | 25138544 |
US |
2 | 2 |
Dry skin, Pruritus, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 52 | 25138649 |
US |
||
Inappropriate schedule of product administration, |
||||
CABOTEGRAVIR, |
||||
| 53 | 25138658 |
US |
71 | 1 |
Inappropriate schedule of product administration, Accidental overdose, |
||||
DULAGLUTIDE, |
||||
| 54 | 25137168 |
JP |
1 | |
Death, Inappropriate schedule of product administration, |
||||
RADIUM RA 223 DICHLORIDE, |
||||
| 55 | 25137190 |
US |
15 | 2 |
Dermatitis atopic, Eyelid skin dryness, Erythema of eyelid, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 56 | 25137367 |
US |
36 | 1 |
Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 57 | 25137424 |
US |
75 | 1 |
Wrong technique in device usage process, Product dose omission issue, Inappropriate schedule of product administration, Intentional dose omission, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 58 | 25137615 |
US |
66 | 2 |
Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 59 | 25137725 |
FR |
53 | 2 |
Feeling abnormal, Fatigue, Retinal vein occlusion, Anaemia, Road traffic accident, Fall, Craniocerebral injury, Vertigo, Cervical vertebral fracture, Back disorder, Hand dermatitis, Deafness, Dyspnoea, Dizziness, Chest pain, Inappropriate schedule of product administration, Mouth ulceration, Influenza, Eczema, Fear of falling, Drug intolerance, Tachycardia, Pain in extremity, Fear, Polyuria, Drug ineffective, Dry mouth, Lip injury, Serum ferritin decreased, |
||||
SPIRONOLACTONE, |
||||
| 60 | 25137824 |
US |
10 | 2 |
Viral infection, Pyrexia, Eating disorder, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 61 | 25137930 |
US |
81 | 1 |
Skin fissures, Dry skin, Pruritus, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 62 | 25137967 |
US |
9 | 2 |
Inappropriate schedule of product administration, Product prescribing issue, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 63 | 25138018 |
US |
41 | 1 |
Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 64 | 25138025 |
US |
1 | |
Asthma, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 65 | 25138055 |
US |
11 | 2 |
Incorrect dose administered, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 66 | 25138079 |
US |
10 | 1 |
Pruritus, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 67 | 25140816 |
83 | 1 | |
Hypotension, Weight decreased, Sepsis, Pneumonia aspiration, Acute respiratory failure, Respiratory failure, Acute kidney injury, Urinary tract infection, Pseudomonas infection, Blood culture positive, Laboratory test interference, Staphylococcal infection, Skin disorder, Dysphagia, Malnutrition, Hypophagia, Dysarthria, Headache, Neck pain, Facial paralysis, Gait disturbance, Cerebrovascular accident, Inappropriate schedule of product administration, |
||||
PEMBROLIZUMAB, |
||||
| 68 | 25132163 |
US |
15 | 2 |
Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 69 | 25132206 |
CA |
72 | 2 |
Blood pressure systolic increased, Kyphosis, Dyspnoea exertional, Feeling abnormal, Forced vital capacity decreased, FEV1/FVC ratio decreased, Inflammation, Pain in extremity, Nasopharyngitis, Obstructive airways disorder, Musculoskeletal chest pain, Headache, Inappropriate schedule of product administration, Overdose, Chronic spontaneous urticaria, Cough, Asthma, Dizziness, Dyspnoea, Weight decreased, Fatigue, Rash, |
||||
CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CALCIUM, EZETIMIBE, EZETIMIBE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LEVOTHYROXINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, HYDROCHLOROTHIAZIDE, LEVOTHYROXINE SODIUM, ROSUVASTATIN CALCIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 70 | 25132290 |
US |
32 | 2 |
Injection site pain, Dermatitis atopic, Therapeutic response decreased, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 71 | 25132301 |
US |
62 | 2 |
Bacterial infection, Rash pruritic, Acarodermatitis, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, TIRZEPATIDE, |
||||
| 72 | 25132306 |
CA |
69 | 2 |
Abdominal distension, Abscess limb, Alopecia, Arthralgia, Breast abscess, Faeces soft, General physical health deterioration, Large intestine polyp, Subcutaneous abscess, Inappropriate schedule of product administration, Off label use, Abdominal pain, Dry eye, Fatigue, Myalgia, |
||||
ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, |
||||
| 73 | 25132323 |
CA |
14 | 2 |
Pharyngitis streptococcal, Rash, Inappropriate schedule of product administration, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 74 | 25132393 |
CA |
26 | 2 |
Juvenile idiopathic arthritis, Off label use, Drug ineffective for unapproved indication, Inappropriate schedule of product administration, |
||||
CERTOLIZUMAB PEGOL, FOLIC ACID, METHOTREXATE SODIUM, NAPROXEN AND ESOMEPRAZOLE MAGNESIUM, CITALOPRAM, CITALOPRAM HYDROBROMIDE, ETANERCEPT, FOLIC ACID, |
||||
| 75 | 25132458 |
AU |
42 | 2 |
Uveitis, Bradyphrenia, Fatigue, Dizziness, Facial pain, Inappropriate schedule of product administration, Product dose omission issue, |
||||
SEMAGLUTIDE, |
||||
| 76 | 25132509 |
US |
1 | |
No adverse event, Inappropriate schedule of product administration, Product availability issue, Product dose omission issue, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 77 | 25132730 |
CA |
||
Haemolytic anaemia, Infusion related hypersensitivity reaction, Inappropriate schedule of product administration, Off label use, Intentional product use issue, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALENDRONATE SODIUM, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, CANDESARTAN, EMPAGLIFLOZIN, FOLIC ACID, GABAPENTIN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISONE, ALBUTEROL SULFATE, ALBUTEROL, SEMAGLUTIDE, |
||||
| 78 | 25132923 |
US |
72 | |
Extra dose administered, Inappropriate schedule of product administration, |
||||
DULAGLUTIDE, |
||||
| 79 | 25133425 |
US |
||
Inappropriate schedule of product administration, |
||||
SECUKINUMAB, |
||||
| 80 | 25133662 |
59 | 2 | |
Therapeutic response unexpected, Therapy partial responder, Overdose, Inappropriate schedule of product administration, Product prescribing error, |
||||
SOLRIAMFETOL, SOLRIAMFETOL, SOLRIAMFETOL, SOLRIAMFETOL, NAPROXEN, NAPROXEN SODIUM, RIMEGEPANT SULFATE, DEXLANSOPRAZOLE, DEXLANSOPRAZOLE, CYCLOBENZAPRINE, CYCLOBENZAPRINE, CLONIDINE, |
||||
| 81 | 25133687 |
40 | 2 | |
Feeling abnormal, Abdominal discomfort, Nausea, Dizziness, Drug effect less than expected, Inappropriate schedule of product administration, Product prescribing error, |
||||
SOLRIAMFETOL, SOLRIAMFETOL, SOLRIAMFETOL, |
||||
| 82 | 25133721 |
US |
||
Inappropriate schedule of product administration, Nausea, Blood glucose abnormal, Weight decreased, |
||||
EXENATIDE, |
||||
| 83 | 25134069 |
US |
||
Weight increased, Inappropriate schedule of product administration, |
||||
RELUGOLIX, RELUGOLIX, RELUGOLIX, |
||||
| 84 | 25134561 |
CA |
21 | 2 |
Ovarian cyst, Endometrial adenocarcinoma, Exposure during pregnancy, Nausea, Hydronephrosis, Nephrolithiasis, Disease complication, Caesarean section, Dehydration, Procedural pain, Weight decreased, Fatigue, Constipation, Infection, Food aversion, Inappropriate schedule of product administration, Off label use, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 85 | 25134590 |
US |
1 | |
Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 86 | 25134629 |
US |
||
Product use in unapproved indication, Inappropriate schedule of product administration, Accidental use of placebo, Packaging design issue, Manufacturing issue, |
||||
| 87 | 25134638 |
US |
||
Inappropriate schedule of product administration, Drug ineffective, |
||||
LEVONORGESTREL, |
||||
| 88 | 25134718 |
US |
76 | 2 |
Pneumonia pseudomonal, Systemic lupus erythematosus, Dyspnoea, Gastrooesophageal reflux disease, Decreased activity, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 89 | 25134731 |
US |
20 | 1 |
Erythema, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 90 | 25134736 |
US |
20 | 2 |
Inappropriate schedule of product administration, |
||||
BELIMUMAB, |
||||
| 91 | 25134945 |
US |
72 | 1 |
Pruritus, Inappropriate schedule of product administration, Incorrect dose administered, Wrong technique in product usage process, |
||||
DUPILUMAB, |
||||
| 92 | 25135040 |
CA |
71 | 2 |
Inappropriate schedule of product administration, Device issue, |
||||
ADALIMUMAB-AFZB, ADALIMUMAB-AFZB, FOLIC ACID, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 93 | 25135217 |
US |
54 | 1 |
Injection site erythema, Inappropriate schedule of product administration, |
||||
DUPILUMAB, |
||||
| 94 | 25135218 |
US |
19 | 2 |
Pruritus, Dermatitis atopic, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 95 | 25135224 |
IT |
14 | 1 |
Ventricular fibrillation, Arrhythmic storm, Product use in unapproved indication, Product administered to patient of inappropriate age, Inappropriate schedule of product administration, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 96 | 25135283 |
JP |
8 | 2 |
Immune-mediated adrenal insufficiency, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Chest pain, Dyspnoea, Immune-mediated endocrinopathy, Immune-mediated hyperthyroidism, Physical deconditioning, Blood creatinine abnormal, |
||||
PEMBROLIZUMAB, |
||||
| 97 | 25135332 |
GB |
1 | |
Crohn^s disease, Inappropriate schedule of product administration, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 98 | 25135415 |
US |
68 | 2 |
Inappropriate schedule of product administration, Overdose, |
||||
IXEKIZUMAB, IXEKIZUMAB, |
||||
| 99 | 25135569 |
GB |
2 | |
Lower respiratory tract infection, Chronic obstructive pulmonary disease, Inappropriate schedule of product administration, |
||||
SECUKINUMAB, OXYCODONE HYDROCHLORIDE, OXYCODONE, PREGABALIN, |
||||
| 100 | 25135684 |
US |
2 | |
Stress, Inappropriate schedule of product administration, Product supply issue, |
||||
OFATUMUMAB, OFATUMUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28